PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8837313-0	1996	The ACE-inhibitor lisinopril affects plasma insulin levels but not fibrinolytic parameters.	Lisinopril	18-28	insulin	Homo sapiens	44-51	
8837313-7	1996	Stimulated levels of insulin during glucose tolerance test also significantly decreased by lisinopril (peak insulin from 57 +/- 10 to 41.2 +/- 7.3 uU/ml, p < or = 0.02).	Lisinopril	91-101	insulin	Homo sapiens	21-28	
8837313-7	1996	Stimulated levels of insulin during glucose tolerance test also significantly decreased by lisinopril (peak insulin from 57 +/- 10 to 41.2 +/- 7.3 uU/ml, p < or = 0.02).	Lisinopril	91-101	insulin	Homo sapiens	108-115	
8837313-9	1996	Our data confirm a beneficial effect of lisinopril on plasma levels of insulin but failed to demonstrate any profibrinolytic effect in this study population, thus questioning the postulated mechanism of influencing endogenous fibrinolysis by changes of plasma insulin.	Lisinopril	40-50	insulin	Homo sapiens	71-78